Fabrizio Carnevale‐Schianca

Author

Also Known As

F Carnevale-Schianca, F. Carnevale-Schianca, F. CarnevaleSchianca, Fabrizio Carnevale-Schianca, Fabrizio Carnevale‐Schianca, Gianna Baroni, Jacopo Peccatori, Paruzzo, Luca

127

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Candiolo Cancer Institute University of Turin University of Washington Fred Hutch Cancer Center Istituti di Ricovero e Cura a Carattere Scientifico

About

Fabrizio Carnevale‐Schianca is an author at Candiolo Cancer Institute specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	382
2	Immunology	3	3	204
3	Cell Biology	1	1	80
4	Cellular Therapies	1	1	80
5	Marrow Transplantation	1	1	20

Fabrizio Carnevale‐Schianca

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
A Comparison of Allografting with Autografting for Newly Diagnosed Myeloma Benedetto Bruno, Marcello Rotta, Francesca Patriarca, New England Journal of Medicine	2007	504
Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers Dario Sangiolo, Emanuela Martinuzzi, Maja Todorovic, International Immunology	2008	130
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma Luisa Giaccone, Barry E. Storer, Francesca Patriarca, Blood	2011	123
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD T Furlong, Paul J. Martin, Mary E.D. Flowers, Bone Marrow Transplantation Mycophenolate MofetilMedical TreatmentClinical TherapeuticPharmacologyTreatment Option	2009	106
Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni, Cancer Investigation OncologySkin CancerMelanomaPharmacologyImmunology	2014	104
Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo Benedetto Bruno, Marcello Rotta, Francesca Patriarca, Blood	2008	98
Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features Loretta Gammaitoni, Lidia Giraudo, Valeria Leuci, Clinical Cancer Research	2013	87
Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas Dario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, Cancer Research InflammationCytokineStem Cell GeneCell TherapyMedicine	2013	80
Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors Fabrizio Carnevale‐Schianca, Daniela Caravelli, Susanna Gallo, Biology of Blood and Marrow Transplantation	2016	59
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program Fabio Guolo, Luana Fianchi, Paola Minetto, Blood Cancer Journal	2020	56

Page 1